Freestone Capital Holdings’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-150,681
Closed -$363K 556
2025
Q2
$363K Buy
+150,681
New +$371K 0.01% 334
2023
Q3
Sell
-10,383
Closed -$57.5K 401
2023
Q2
$57.5K Hold
10,383
﹤0.01% 374
2023
Q1
$59.1K Buy
+10,383
New +$68.7K ﹤0.01% 354
2022
Q3
Sell
-11,186
Closed -$116K 416
2022
Q2
$116K Buy
+11,186
New +$166K ﹤0.01% 403

Other funds holding MSOS

Freestone Capital Holdings's MSOS Position: Q3 2025 in Review

Freestone Capital Holdings sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2025, closing a stake of 150,681 shares — an estimated $363K sold.

Freestone Capital Holdings first reported a position in MSOS in Q2 2022 and held it in 4 quarters. The position peaked at $363K in Q2 2025. 171 funds tracked by Wall St. Rank hold MSOS as of Q3 2025.

  • Freestone Capital Holdings reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2025 after selling out during the quarter.
  • Freestone Capital Holdings sold 150,681 AdvisorShares Pure US Cannabis ETF shares in Q3 2025, an estimated $363K.
  • Freestone Capital Holdings first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2022 and held it in 4 quarters.
  • Freestone Capital Holdings's AdvisorShares Pure US Cannabis ETF position peaked at $363K in Q2 2025.
  • 171 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2025.

Based on Freestone Capital Holdings's 13F filing for Q3 2025, filed 12 Nov 2025.